Skip to content

The American Society for Preventive Cardiology

JOIN        LOGIN        CONTACT

The American Society for Preventive Cardiology

  • Join
  • Login
  • Contact Us
aspc-logo-219
  • About Us
    • History
    • Board of Directors
    • Executive Team
    • Corporate Partners
    • Collaborations
    • Awards
    • News
    • Frequently Asked Questions
    • Contact Us
  • Clinical Resources
    • Tools for Patients
      • INTERVENT
      • FH Insurance Guide
      • Prep for a Telehealth Visit
      • FH Fact Sheet
    • Tools for Providers
      • American Journal of Preventive Cardiology
      • DocMatter Login
      • Guidelines
      • Infographics
      • Articles & Publications
      • Scientific Statements
      • COVID-19 Resources
      • ASPC Mobile App
      • PCSK9 Inhibitor Access
      • Educational Presentations
      • Podcasts
    • Videos
      • COVID-19 and the Heart: 5 Things You Should Know
      • Continuity of Care in Patients with/at High Risk for CVD During the COVID-19 Pandemic
      • Emory Cardiovascular Risk Reduction in Young Adults webinar series
      • Doing Well by Doing Good: The Business of CV Prevention
      • ASPC Update on the 2019 ACC/AHA Prevention Guidelines Webinar
      • ASPC Update on the New 2018 Cholesterol Guidelines Webinar
      • PCSK9 Inhibitors: Access Barriers Affect Real People
      • Accessing Breakthrough Cholesterol Treatments
  • Membership
    • Manage Account
    • Join ASPC
    • Member Benefits
    • ASPC Working and Interest Groups
    • DocMatter Login
    • Member Search
  • Professional Development
    • 2022 Annual Congress
    • 2021 Virtual Summit
    • 2021 Experts Course
    • Events Center
    • Online CME
    • Expert Lectures
    • Fellow of the ASPC
    • ASPC Manual of Preventive Cardiology
  • Careers
    • Job Board
    • Resources
  • Journal
  • About Us
    • History
    • Board of Directors
    • Executive Team
    • Corporate Partners
    • Collaborations
    • Awards
    • News
    • Frequently Asked Questions
    • Contact Us
  • Clinical Resources
    • Tools for Patients
      • INTERVENT
      • FH Insurance Guide
      • Prep for a Telehealth Visit
      • FH Fact Sheet
    • Tools for Providers
      • American Journal of Preventive Cardiology
      • DocMatter Login
      • Guidelines
      • Infographics
      • Articles & Publications
      • Scientific Statements
      • COVID-19 Resources
      • ASPC Mobile App
      • PCSK9 Inhibitor Access
      • Educational Presentations
      • Podcasts
    • Videos
      • COVID-19 and the Heart: 5 Things You Should Know
      • Continuity of Care in Patients with/at High Risk for CVD During the COVID-19 Pandemic
      • Emory Cardiovascular Risk Reduction in Young Adults webinar series
      • Doing Well by Doing Good: The Business of CV Prevention
      • ASPC Update on the 2019 ACC/AHA Prevention Guidelines Webinar
      • ASPC Update on the New 2018 Cholesterol Guidelines Webinar
      • PCSK9 Inhibitors: Access Barriers Affect Real People
      • Accessing Breakthrough Cholesterol Treatments
  • Membership
    • Manage Account
    • Join ASPC
    • Member Benefits
    • ASPC Working and Interest Groups
    • DocMatter Login
    • Member Search
  • Professional Development
    • 2022 Annual Congress
    • 2021 Virtual Summit
    • 2021 Experts Course
    • Events Center
    • Online CME
    • Expert Lectures
    • Fellow of the ASPC
    • ASPC Manual of Preventive Cardiology
  • Careers
    • Job Board
    • Resources
  • Journal
Search
Close

Novartis Entresto® granted expanded indication in chronic heart failure by FDA

By ASPC | February 18, 2021

Read the Press Release

Posted in ASPC News
JOIN ASPC
LOGIN

Contact

The American Society for Preventive Cardiology
450-106 SR 13 N, #140
Jacksonville, FL 32259

Phone: (904) 217-7407
Email: contact@aspconline.org

  • Home
  • About Us
  • Membership
  • News
  • Contact Us
  • DocMatter Login
  • Intervent

Latest News

REGENERON AND ULTRAGENYX COLLABORATE TO COMMERCIALIZE EVKEEZA® (EVINACUMAB) OUTSIDE THE UNITED STATES

Evkeeza is a first-in-class medicine approved by the U.S. Food and Drug…

FDA Approval of LEQVIO(R) (inclisiran)

Novartis has announced that LEQVIO® (inclisiran) has been approved by the FDA…

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Read More

Connect with us

SUBSCRIBE NOW

Get notified with latest updates, press releases, webinars and more!

© 2019 The American Society for Preventive Cardiology. All Rights Reserved. Privacy Policy

Scroll To Top